Value of 111In-Pentetreotide scintigraphy and 18F-FDG PET for clinical prognosis of patients with neuroendocrine neoplasms

Autor: Gouffon, M., Prior, J.O., Larche, M., Krause, T.M., Pralong, F.P.
Zdroj: In Médecine Nucléaire September 2019 43(4):316-322
Databáze: ScienceDirect